re: more good arixtra news yes I think GSK are going to drive arixtra market share. Every quarter or so they come up with more studies showing its effectiveness over lov.
this is great for alchemia with a low cost form of arixtra.
- Forums
- ASX - By Stock
- TSN
- who is the seller/s
who is the seller/s, page-13
Featured News
Add TSN (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable